Click a link below to view the mailing archive as if it had been sent to you.
| 2017-09-30 12:15 | | FDA Launches Searchable Adverse Event Database for Drugs and Biologics and more... |
| 2017-09-29 12:15 | | Big Pharma Doesn't Want Health Outcomes To Sway Pricing -- At Least Not Yet and more... |
| 2017-09-29 00:15 | | PhRMA supports script limits to cut opioid abuse and more... |
| 2017-09-28 12:15 | | Study Finds FDA Action on Unapproved Drugs Led to Higher Prices, Longer Shortages and more... |
| 2017-09-28 00:15 | | Right After Trump Blamed High Drug Prices On Campaign Cash, Drugmakers Gave More |
| 2017-09-27 12:15 | | Small is big: Pharma’s R&D brain drain continues as GSK’s Chris Carpenter jumps to upstart Rubius and more... |
| 2017-09-27 00:15 | | Sinovac’s chickenpox vaccine shows 87% efficacy in topline phase 3 and more... |
| 2017-09-26 12:15 | | Axovant's closely watched Alzheimer's drug fails late-stage trial and more... |
| 2017-09-26 00:15 | | What pledge? AbbVie executives may back off their vow to limit price hikes: report and more... |
| 2017-09-25 12:15 | | Five Reasons Why Toronto is Emerging as a Major Life Sciences Hub and more... |
| 2017-09-24 12:15 | | Biotech: The Big Payoff and more... |
| 2017-09-23 12:15 | | CVS to limit opioid prescriptions to 7 days and more... |
| 2017-09-22 12:15 | | Why Is Cash-Rich Gilead Sciences, Inc. Borrowing $3 Billion? and more... |
| 2017-09-22 00:15 | | Pfizer's fast-growing Ibrance romps toward an early $5B payoff: analyst and more... |
| 2017-09-21 12:15 | | Will Amazon really get into drug sales? It's in talks with PBMs already, report says and more... |
| 2017-09-21 00:15 | | 2 Important Dates for Big Pharma and more... |
| 2017-09-20 12:15 | | Pfizer files US lawsuit against Johnson & Johnson over "anticompetitive" practices related to Remicade biosimilar and more... |
| 2017-09-20 00:15 | | Drug Industry Denied Fast Relief in Nevada Price Law Challenge and more... |
| 2017-09-19 12:15 | | This pharma CEO won praise for his ‘social contract’ with the public. But his latest move could shred that pledge and more... |
| 2017-09-19 00:15 | | FDA clears Medtronic's next-generation spinal cord stimulator and more... |
| 2017-09-18 12:15 | | Sanofi and Amgen, eyeing boost for PCSK9 use, tout benefits for diabetes patients and more... |
| 2017-09-17 12:15 | | 10 Rock-Solid Reasons Johnson & Johnson's Near-Term Future Looks Bright and more... |
| 2017-09-17 00:15 | | Why Amgen, Lilly, J&J Are Interested In These Small Biotechs and more... |
| 2017-09-16 12:15 | | Bayer gears up to take on Gilead in lymphoma with Aliqopa green light and more... |
| 2017-09-15 12:15 | | Cash-strapped Teva closes in on women's health sale No. 2: report and more... |
| 2017-09-15 00:15 | | AstraZeneca's Bydureon fails to show cardio-protection and more... |
| 2017-09-14 12:15 | | EASD: Boehringer Ingelheim, Lilly's Jardiance holds CV benefit regardless of blood sugar starting point and more... |
| 2017-09-14 00:15 | | Interchangeable Biosimilars vs. Biosimilars: Experts Explain Guidance, Discuss Development and Uptake and more... |
| 2017-09-13 12:15 | | Cancer patients know immuno-oncology and top drugs, but lack details: study and more... |
| 2017-09-13 00:15 | | 3,500 Job Cuts at Eli Lilly Signal Change in Focus and more... |
| 2017-09-12 12:15 | | Study says drug development costs much less than previously estimated and more... |
| 2017-09-12 00:15 | | Teva makes good on asset-sale vows with $1.1B contraceptive sale and more... |
| 2017-09-11 12:15 | | Troubled Teva poaches Lundbeck CEO Schultz with an offer he couldn’t refuse, including $20M in cash and more... |
| 2017-09-11 00:15 | | AstraZeneca CEO, worried by Brexit, not signing UK government letter |
| 2017-09-10 12:15 | | Quest Diagnostics rolls out more accurate, nonfasting cholesterol tests and more... |
| 2017-09-10 00:15 | | ESMO: AstraZeneca's Tagrisso bests rivals at holding off EGFR lung cancer growth and more... |
| 2017-09-09 12:15 | | 2 Big Reasons Exelixis, Inc. Added $626 Million to Its Market Cap in August |
| 2017-09-08 12:15 | | ESMO: Merck piles on the positive Keytruda-chemo combo results in lung cancer and more... |
| 2017-09-08 00:15 | | [video+transcript]Are These Healthcare Stocks Top Takeover Targets? and more... |
| 2017-09-07 12:15 | | Drugmaker Lilly to trim workforce by nearly 9 percent and more... |
| 2017-09-07 00:15 | | Insys ignored warnings about marketing powerful opioid Subsys and more... |
| 2017-09-06 12:15 | | Nordisk settles DOJ’s Victoza marketing suit for $59m and more... |
| 2017-09-06 00:15 | | Stryker closes $700m Novadaq buy and more... |
| 2017-09-05 12:15 | | Can marketing techniques save clinical trials? and more... |
| 2017-09-05 00:15 | | 3 Strong Biotech Stocks In 2017 and more... |
| 2017-09-04 12:15 | | Novartis follows up on big CAR-T win by naming Vas Narasimhan as its new CEO and more... |
| 2017-09-02 12:15 | | 3 Reasons Gilead Sciences Jumped to Buy Kite Pharma and more... |
| 2017-09-02 00:15 | | Neurotoxicity kills a CAR-T rival pushed by J&J, MacroGenics in $700M deal and more... |
| 2017-09-01 12:15 | | Fewer pharma job cuts so far in 2017 and more... |
| 2017-09-01 00:15 | | FDA Alerts on Risks From Merck’s Keytruda in Multiple Myeloma Following Halted Trials and more... |
